Therapeutic Areas

Phase I–IV Clinical Trials Across The Middle East, Africa, Pakistan & EAEU

Our focus spans Phase I–IV trials, observational studies, regulatory support across therapeutic areas

65%

15%

10%

Phase I-IV

Observational

Regulatory

FSP

Others

Phase I–IV Clinical Trials Across MEA, Pakistan & EAEU

Our focus spans Phase I–IV trials, observational studies, regulatory support, and more

Hematology

Indications:
· Hemophilia A & B
· Immune Thrombocytopenia (ITP)
· Sickle Cell Disease
· Von Willebrand Disease
· β Thalassemia

Oncology

Indications:
· Breast Cancer
· Lung Cancer
· Ovarian Cancer
· Prostate Cancer
· Acute Myeloid Leukemia (AML)

Genetic Diseases

Indications:
· Duchenne Muscular Dystrophy (DMD)
· Fabry Disease
· Gaucher Disease
· Spinal Muscular Atrophy (SMA)
· Angelman Syndrome

Infectious Diseases

Indications:
· HIV
· Hepatitis C
· COVID-19
· Influenza
· Tuberculosis

Gastroenterology

Indications:
· Crohn’s Disease
· Ulcerative Colitis
· IBS
· Hemorrhoids
· ETEC Diarrhea

Neurology

Indications:
· Multiple Sclerosis
· Epilepsy
· Generalized Myasthenia Gravis
· Cervical Dystonia
· Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Nephrology

Indications:
· Chronic Kidney Disease (CKD)
· IgA Nephropathy
· Hyperkalaemia
· Kidney Transplant
· Primary Hyperoxaluria

Ophthalmology

Indications:
· Age-Related Macular Degeneration (AMD)
· Glaucoma
· Diabetic Macular Edema (DME)
· Thyroid Eye Disease (TED)
· Ocular Myasthenia Gravis

Others

Indications:
· Cardiovascular
· Dermatology
· Dyslipidemia
· Endocrinology
· Gynecology
· Hepatology
· Mental Health
· Nutrition
· Pulmonary
· Rheumatology
· Surgery